Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
550 participants
INTERVENTIONAL
2018-03-15
2023-02-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians
NCT00608387
Translating a Heart Disease Lifestyle Intervention Into the Community
NCT01647438
Developing a Lifestyle Intervention for South Asians
NCT03861546
Low Literacy CVD Diet Education for Blacks
NCT00005725
Implementation of a Peer Leader-facilitated Dyadic Intervention
NCT06643806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Print Health Education
Participants will receive primary care referrals and print health education material about heart disease prevention in the mail.
No interventions assigned to this group
SAHELI Intervention
Participants will enroll in heart disease prevention group sessions focusing on physical activity, diet, weight, and stress management. Each group will have 16 to 20 participants who will attend 16 weekly, 90 minute group education sessions at Metropolitan Asian Family Services or Skokie Health Department. During each session, participants will watch videos on the day's topic followed by discussion, activities, and assistance in setting realistic goals with attention to physical activity, diet, weight, and stress management.
South Asian Healthy Lifestyle Initiative (SAHELI)
Culturally tailored lifestyle intervention for South Asians.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
South Asian Healthy Lifestyle Initiative (SAHELI)
Culturally tailored lifestyle intervention for South Asians.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living within the 22 square mile study area
* Ability to understand Hindi, Urdu, Gujarati or English. AND
Body Mass Index of 25 and over and a diagnosis by a doctor of high cholesterol or pre-diabetes/Diabetes, or High blood pressure. OR Body Mass Index of 23 to 24.9 and one clinical risk factors for Cardiovascular Disease (CVD) (CVD risk factors are: Hypertension (Systolic blood pressure \>=130 or diastolic blood pressure \>=80), abnormal cholesterol (Total cholesterol ≥200, triglycerides \>=150),pre-diabetes (A1c between 5.7-6.4%), or diabetes (A1c 6.5 to 10.9),
Exclusion Criteria
* Being on insulin
* Blood pressure ≥180/100 mmHg
* HbA1c ≥11% BMI ≥ 40
* Current pregnancy
* Being ≤ 12 months postpartum
* Any underlying diseases likely to limit lifespan and/or affects ability to exercise.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Metropolitan Asian Family Services
UNKNOWN
Skokie Health Department
UNKNOWN
Endeavor Health
OTHER
Case Western Reserve University
OTHER
Shirley Ryan AbilityLab
OTHER
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Namratha Kandula
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Namratha Kandula, MD,MPH
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kandula NR, Bernard V, Dave S, Ehrlich-Jones L, Counard C, Shah N, Kumar S, Rao G, Ackermann R, Spring B, Siddique J. The South Asian Healthy Lifestyle Intervention (SAHELI) trial: Protocol for a mixed-methods, hybrid effectiveness implementation trial for reducing cardiovascular risk in South Asians in the United States. Contemp Clin Trials. 2020 May;92:105995. doi: 10.1016/j.cct.2020.105995. Epub 2020 Mar 24.
Lam EL, Kandula NR, Shah NS. The Role of Family Social Networks in Cardiovascular Health Behaviors Among Asian Americans, Native Hawaiians, and Pacific Islanders. J Racial Ethn Health Disparities. 2023 Oct;10(5):2588-2599. doi: 10.1007/s40615-022-01438-9. Epub 2022 Nov 3.
Vu M, Nedunchezhian S, Lancki N, Spring B, Brown CH, Kandula NR. A mixed-methods, theory-driven assessment of the sustainability of a multi-sectoral preventive intervention for South Asian Americans at risk for cardiovascular disease. Implement Sci Commun. 2024 Sep 13;5(1):89. doi: 10.1186/s43058-024-00626-4.
Kandula NR, Shah NS, Kumar S, Charley M, Clauson M, Lancki N, Finch EA, Ehrlich-Jones L, Rao G, Spring B, Shah NS, Siddique J. Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial. JAMA Cardiol. 2024 Nov 1;9(11):973-981. doi: 10.1001/jamacardio.2024.2526.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00204939
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.